Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Xin Xu^#^{1

2}, Jian Sun^#^{1

2}, Sheng Nie^#^{1

2}, Huiyuan Li^#³, Yaozhong Kong^#⁴, Min Liang^{1

2}, Jinlin Hou^{1

2}, Xianzhong Huang³, Dongfeng Li⁵, Tean Ma⁶, Jiaqing Peng⁷, Shikui Gao⁸, Yong Shao⁹, Hong Zhu², Johnson Yiu-Nam Lau¹⁰, Guangyu Wang¹¹, Chunbao Xie¹², Li Jiang¹², Ailong Huang¹³, Zhenglin Yang¹⁴, Kang Zhang^{15

16}, Fan Fan Hou^{17

18

19}

Affiliations

¹ State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China.
² Nanfang Hospital, Southern Medical University, Guangzhou, China.
³ Kingmed Center for Clinical Laboratory, Guangzhou, China.
⁴ The First People's Hospital of Foshan, Foshan, China.
⁵ The People's Hospital of Honghu, Honghu, China.
⁶ The First People's Hospital of Jingzhou, Jingzhou, China.
⁷ Jingzhou Central Hospital, Jingzhou, China.
⁸ Honghu Traditional Chinese Medicine Hospital, Honghu, China.
⁹ The Second People's Hospital of Honghu, Honghu, China.
¹⁰ Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Hong Kong, China.
¹¹ Department of Computer Science and Technology, Tsinghua University, Beijing, China.
¹² The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
¹³ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. ahuang1964@163.com.
¹⁴ The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. zliny@yahoo.com.
¹⁵ Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China. kang.zhang@gmail.com.
¹⁶ Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. kang.zhang@gmail.com.
¹⁷ State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China. ffhouguangzhou@163.com.
¹⁸ Nanfang Hospital, Southern Medical University, Guangzhou, China. ffhouguangzhou@163.com.
¹⁹ Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. ffhouguangzhou@163.com.

^# Contributed equally.

PMID: 32812013
PMCID: PMC7433269
DOI: 10.1038/s41591-020-1058-2

Published Erratum

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Xin Xu et al. Nat Med. 2020 Sep.

. 2020 Sep;26(9):1494.

doi: 10.1038/s41591-020-1058-2.

Authors

Affiliations

¹ State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China.
² Nanfang Hospital, Southern Medical University, Guangzhou, China.
³ Kingmed Center for Clinical Laboratory, Guangzhou, China.
⁴ The First People's Hospital of Foshan, Foshan, China.
⁵ The People's Hospital of Honghu, Honghu, China.
⁶ The First People's Hospital of Jingzhou, Jingzhou, China.
⁷ Jingzhou Central Hospital, Jingzhou, China.
⁸ Honghu Traditional Chinese Medicine Hospital, Honghu, China.
⁹ The Second People's Hospital of Honghu, Honghu, China.
¹⁰ Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Hong Kong, China.
¹¹ Department of Computer Science and Technology, Tsinghua University, Beijing, China.
¹² The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
¹³ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. ahuang1964@163.com.
¹⁴ The Sichuan Provincial Key Laboratory of Human Disease Study, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. zliny@yahoo.com.
¹⁵ Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China. kang.zhang@gmail.com.
¹⁶ Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. kang.zhang@gmail.com.
¹⁷ State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangzhou, China. ffhouguangzhou@163.com.
¹⁸ Nanfang Hospital, Southern Medical University, Guangzhou, China. ffhouguangzhou@163.com.
¹⁹ Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China. ffhouguangzhou@163.com.

^# Contributed equally.

PMID: 32812013
PMCID: PMC7433269
DOI: 10.1038/s41591-020-1058-2

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
Xu X, Sun J, Nie S, Li H, Kong Y, Liang M, Hou J, Huang X, Li D, Ma T, Peng J, Gao S, Shao Y, Zhu H, Lau JY, Wang G, Xie C, Jiang L, Huang A, Yang Z, Zhang K, Hou FF. Xu X, et al. Nat Med. 2020 Aug;26(8):1193-1195. doi: 10.1038/s41591-020-0949-6. Epub 2020 Jun 5. Nat Med. 2020. PMID: 32504052

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Affiliations

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous